Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations - Tập 30 - Trang 886-892 - 2012
Bo Yin1, Gang Liu1, Xiao-Song Wang2,3,4, Hui Zhang1, Yong-Sheng Song1, Bin Wu1
1Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China
2Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA
3National Center for Integrative Biomedical Informatics, CCMB, Ann Arbor, MI 48109, USA
4Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA

Tài liệu tham khảo

Patton, 2002, Bladder cancer, Curr Opin Oncol, 14, 265, 10.1097/00001622-200205000-00003

Amling, 2001, Diagnosis and management of superficial bladder cancer, Curr Probl Cancer, 25, 219, 10.1067/mcn.2001.117539

Nseyo, 1997, Immunotherapy of bladder cancer, Semin Surg Oncol, 13, 342, 10.1002/(SICI)1098-2388(199709/10)13:5<342::AID-SSU8>3.0.CO;2-D

Chen, 2009, Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer, Int J Cancer, 124, 2893, 10.1002/ijc.24296

Zendman, 2003, Cancer/testis-associated genes: Identification, expression profile, and putative function, J Cell Physiol, 194, 272, 10.1002/jcp.10215

Scanlan, 2002, Cancer/testis antigens: An expanding family of targets for cancer immunotherapy, Immunol Rev, 188, 22, 10.1034/j.1600-065X.2002.18803.x

Scanlan, 2004, The cancer/testis genes: Review, standardization, and commentary, Cancer Immun, 4, 1

van der Bruggen, 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, 254, 1643, 10.1126/science.1840703

Lin, 2004, Melanoma-associated antigens in esophageal adenocarcinoma: Identification of novel MAGE-A10 splice variants, Clin Cancer Res, 10, 5708, 10.1158/1078-0432.CCR-04-0468

Li, 2005, Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue, Clin Cancer Res, 11, 1809, 10.1158/1078-0432.CCR-04-1365

Gerhardt, 2004, Tissue expression and seroreactivity of tumor-specific antigens in colorectal cancer, Cancer Lett, 208, 197, 10.1016/j.canlet.2003.11.021

Usener, 2003, cTAGE: A cutaneous T cell lymphoma associated antigen family with tumor-specific splicing, J Invest Dermatol, 121, 198, 10.1046/j.1523-1747.2003.12318.x

Mooney, 2010, Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential, Biochemistry, 49, 1, 10.1021/bi901263m

Kurashige, 2001, Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade, Cancer Res, 61, 4671

Old, 1998, New paths in human cancer serology, J Exp Med, 187, 1163, 10.1084/jem.187.8.1163

Sahin, 1998, Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies, Int J Cancer, 78, 387, 10.1002/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2

Scanlan, 2000, Expression of cancer-testis antigens in lung cancer: Definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9, Cancer Lett, 150, 155, 10.1016/S0304-3835(99)00385-7

Kocher, 1995, Identification and intracellular location of MAGE-3 gene product, Cancer Res, 55, 2236

Lonchay, 2004, Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen, Proc Natl Acad Sci U S A, 101, 14631, 10.1073/pnas.0405743101

Bolli, 2005, NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: A tissue microarray study, Int J Cancer, 115, 960, 10.1002/ijc.20953

Marturano, 2008, MAGE-A3(161–175) contains an HLA-DRβ4 restricted natural epitope poorly formed through indirect presentation by dendritic cells, Cancer Immunol Immunother, 57, 207, 10.1007/s00262-007-0364-6

Tsuji, 2008, Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient, Cancer Immunol Immunother, 57, 1429, 10.1007/s00262-008-0478-5

Aoki, 2009, Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432, Vaccine, 27, 6854, 10.1016/j.vaccine.2009.09.018

Ait-Tahar, 2009, Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma, Br J Haematol, 146, 396, 10.1111/j.1365-2141.2009.07761.x

Natsume, 2008, The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma, Int J Cancer, 122, 2542, 10.1002/ijc.23407

Bar-Haim, 2004, MAGE-A8 overexpression in transitional cell carcinoma of the bladder: Identification of two tumor-associated antigen peptides, Br J Cancer, 91, 398, 10.1038/sj.bjc.6601968

Thông tin
Thông tin xuất bản

Urologic Oncology: Seminars and Original Investigations

Tập 30

886-892

Thông tin tác giả